Biovaxys Technology Corp - ESG Rating & Company Profile powered by AI
Scroll down to the end of this webpage for potential risks for Biovaxys Technology Corp based on industry, geography and size. If you work at Biovaxys Technology Corp and you wish to use your ESG rating, please get in touch. The webpage displays a zero-cost ESG assessment for Biovaxys Technology Corp.
Biovaxys Technology Corp in the Biotechnology & Medical Research industry gained a UN SDG ESG Transparency Score of 0.0; made up of an environmental score of 0.0, social score of 0.0 and governance score of 0.0.
0.0
Low ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Analytik Jena AG | 8.0 | High |
| 1 | Amniotics AB (publ) | 8.0 | High |
| ... | ... | ... | |
| 179 | Exagen Inc | 0.7 | Low |
| 179 | Mertiva AB | 0.7 | Low |
| 182 | Biovaxys Technology Corp | 0.0 | Low |
| 182 | Cadus Corp | 0.0 | Low |
| 182 | Cambridge Chocolate Technologies SA | 0.0 | Low |
| 182 | Wesana Health Holdings Inc | 0.0 | Low |
| 182 | rEVO Biologics Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Biovaxys Technology Corp have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Biovaxys Technology Corp disclose current and historical energy intensity?
Sign up for free to unlockDoes Biovaxys Technology Corp report the average age of the workforce?
Sign up for free to unlockDoes Biovaxys Technology Corp reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Biovaxys Technology Corp disclose its ethnicity pay gap?
Sign up for free to unlockDoes Biovaxys Technology Corp disclose cybersecurity risks?
Sign up for free to unlockDoes Biovaxys Technology Corp offer flexible work?
Sign up for free to unlockDoes Biovaxys Technology Corp have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Biovaxys Technology Corp disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Biovaxys Technology Corp conduct supply chain audits?
Sign up for free to unlockDoes Biovaxys Technology Corp disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Biovaxys Technology Corp conduct 360 degree staff reviews?
Sign up for free to unlockDoes Biovaxys Technology Corp disclose the individual responsible for D&I?
Sign up for free to unlockDoes Biovaxys Technology Corp disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Biovaxys Technology Corp disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Biovaxys Technology Corp disclose water use targets?
Sign up for free to unlockDoes Biovaxys Technology Corp have careers partnerships with academic institutions?
Sign up for free to unlockDid Biovaxys Technology Corp have a product recall in the last two years?
Sign up for free to unlockDoes Biovaxys Technology Corp disclose incidents of discrimination?
Sign up for free to unlockDoes Biovaxys Technology Corp allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Biovaxys Technology Corp issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Biovaxys Technology Corp disclose parental leave metrics?
Sign up for free to unlockDoes Biovaxys Technology Corp disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Biovaxys Technology Corp disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Biovaxys Technology Corp disclose the pay ratio of women to men?
Sign up for free to unlockDoes Biovaxys Technology Corp support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Biovaxys Technology Corp disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Biovaxys Technology Corp reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Biovaxys Technology Corp involved in embryonic stem cell research?
Sign up for free to unlockDoes Biovaxys Technology Corp disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Biovaxys Technology Corp disclose its waste policy?
Sign up for free to unlockDoes Biovaxys Technology Corp report according to TCFD requirements?
Sign up for free to unlockDoes Biovaxys Technology Corp disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Biovaxys Technology Corp disclose energy use targets?
Sign up for free to unlockDoes Biovaxys Technology Corp disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Biovaxys Technology Corp have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Biovaxys Technology Corp
These potential risks are based on the size, segment and geographies of the company.
BioVaxys Technology Corp., a clinical biotechnology company, develops antiviral and anticancer vaccine platforms. It develops BVX-0320, a monovalent SARS-CoV-2 vaccine; and BVX-0918A, a haptenized tumor cell vaccine for ovarian cancer, as well as CoviDTH, which screens for an immune system response in patients exposed to SARS-CoV-2. The company is also developing Papilocare for human papilloma virus (HPV)-dependent cervical lesions; BVX-0918C for cervical cancer; BVX-0204 HPV viral vaccine; and BVX-0121, a multivalent SARS-CoV-2 vaccine. BioVaxys Technology Corp. has a bioproduction agreement with WuXi Biologics Limited that produces SARS-CoV-2 s-proteins for BVX-0320 and CoviDTH; research collaboration with The Ohio State University, Wexner School of Medicine for BVX-0320; and agreement with Bioanalytical Systems, Inc. to conduct preclinical toxicology studies for its CoviDTH immunodiagnostic. The company is based in Vancouver, Canada.